Neurogenetic Testing Market Anticipated To Witness Robust Growth, Surpassing $1.16 Billion By 2029

The Neurogenetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Neurogenetic Testing Market Size and Its Estimated Growth Rate?
The neurogenetic testing market has seen fast growth. It will grow from $0.61 billion in 2024 to $0.7 billion in 2025 at a CAGR of 13.9%, driven by a rise in neurological conditions, life sciences R&D, more Parkinson's and cancer cases, and growing medical professional awareness.

The neurogenetic testing market is projected to see rapid growth, reaching $1.16 billion by 2029 at a compound annual growth rate (CAGR) of 13.5%. Growth factors include the expanding use of personalized medicine, rising chronic disease rates, an increase in hospitals and diagnostic labs, and demand for early disease detection. Trends include technological advancements, greater adoption of non-invasive testing, new product development, and novel biomarkers for neurological conditions.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16131

How Are Emerging Segments Shaping the Neurogenetic Testing Market Landscape?
The neurogenetic testing market covered in this report is segmented -

1) By Type: Microarray Analysis, Whole-Exome Sequencing (WES), Multiplex Ligation Dependent Probe Amplification (MLPA), Polymerase Chain Reaction (PCR) Tests, Other Types
2) By Disease: Rare Genetic Disorder, Cancer, Cystic Fibrosis, Sickle Cell Anemia, Duchenne Muscular Dystrophy, Thalassemia, Huntington's Disease, Fragile X Syndrome, Other Diseases
3) By End-Users: Hospitals, Specialty Clinics, Research Institutes, Diagnostics Laboratories

Subsegments:
1) By Microarray Analysis: Comparative Genomic Hybridization (CGH) Microarray, Single Nucleotide Polymorphism (SNP) Microarray, Gene Expression Microarray
2) By Whole-Exome Sequencing (WES): Targeted Exome Sequencing, Clinical Exome Sequencing, Research-Grade Exome Sequencing
3) By Multiplex Ligation Dependent Probe Amplification (MLPA): MLPA For Copy Number Variation, MLPA For Methylation Analysis, MLPA For Specific Disease Detection
4) By Polymerase Chain Reaction (PCR) Tests: Quantitative PCR (qPCR), Reverse Transcription PCR (RT-PCR), Digital PCR (dPCR)
5) By Other Types: Next-Generation Sequencing (NGS), Southern Blotting, Fluorescence In Situ Hybridization (FISH), Sanger Sequencing

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16131&type=smp

Which Growth Factors Are Influencing Neurogenetic Testing Market Expansion?
An increasing rate of neurological conditions is anticipated to fuel growth in the neurogenetic testing market. Neurological conditions affect the nervous system and arise due to genetic risks, infections, injuries, toxins, autoimmune reactions, and degeneration. Neurogenetic testing enables more accurate diagnoses and management by offering insights into genetic susceptibility, assisting in personalized treatment choices, and empowering patients and families in healTH*Care decisions. For instance, the European Brain Council reported in April 2022 that more than 600 neurological and nearly 300 psychiatric disorders affect millions worldwide, including 65 million people with epilepsy. Dementia cases in Europe alone are expected to rise from 10.5 million to 18.7 million by 2050. Therefore, the increase in neurological disorders is encouraging the growth of the neurogenetic testing market.

Who Are the Dominant Players Across Different Neurogenetic Testing Market Segments?
Major companies operating in the neurogenetic testing market are Thermo Fisher Scientific Inc., Mayo Clinic, Roche Diagnostics Corporation, Laboratory Corporation, Quest Diagnostics Incorporated, Eurofins Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corporation, Myriad Genetics Inc., BioReference Laboratories Inc., Connecticut Children's, Invitae Corp., Ambry Genetics Corporation, Fulgent Genetics Inc., Blueprint Genetics Inc., GeneDx LLC, Pacific Biosciences of California Inc., MedGenome Labs, CENTOGENE, Baylor Genetics, Victorian Clinical Genetics Services

What Trends Are Expected to Dominate the Neurogenetic Testing Market in the Next 5 Years?
Major companies in the neurogenetic testing market are implementing comprehensive techniques like whole-genome sequencing to broaden genetic analysis capabilities. In March 2024, Nucleus Genomics, a US-based company, released a DNA analysis product offering insights into genetic predispositions, supported by advanced technology and genetic counseling to empower personalized health decisions.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/neurogenetic-testing-global-market-report

Which Geographic Regions Are Expected to Dominate the Neurogenetic Testing Market in the Coming Years?
North America was the largest region in the neurogenetic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Neurogenetic Testing Market?
2. What is the CAGR expected in the Neurogenetic Testing Market?
3. What Are the Key Innovations Transforming the Neurogenetic Testing Industry?
4. Which Region Is Leading the Neurogenetic Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.